Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002.
Kozhimannil KB, Graves AJ, Levy R, Patrick SW. Nonmedical use of prescription opioids among pregnant U.S. women. Womens Health Issues. 2017;27(3):308–15.
Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–9.
Saavedra LG. Neonatal abstinence syndrome surveillance in New Mexico. New Mexico Epidemiology Volume 2018, Number 10 November 30, 2018. https://nmhealth.org/data/view/report/2194/. Accessed 27 Nov 2019.
Yazdy MM, Desai RJ, Brogly SB. Prescription opioids in pregnancy and birth outcomes: a review of the literature. J Pediatr Genet. 2015;4(2):56–70.
Kaltenbach K, O’Grady KE, Heil SH, Salisbury AL, Coyle MG, Fischer G, Martin PR, Stine S, Jones HE. Prenatal exposure to methadone or buprenorphine: early childhood developmental outcomes. Drug Alcohol Depend. 2018;185:40–9.
Bakhireva LN, Holbrook BD, Shrestha S, Leyva Y, Ashley M, Cano S, Lowe J, Stephen JM, Leeman L. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5–8 months of age. Early Human Dev. 2019;128:69–76.
Shrestha S, Roberts MH, Maxwell JR, Leeman LM, Bakhireva LN. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome. Neurotoxicol Teratol. 2021;86:106975.
Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011;21(2):73–80.
Bakhireva LN, Shrestha S, Garrison L, Leeman L, Rayburn WF, Stephen JM. Prevalence of alcohol use in pregnant women with substance use disorder. Drug Alcohol Depend. 2018;187:305–10.
El Marroun H, Bolhuis K, Franken IHA, Jaddoe VWV, Hillegers MH, Lahey BB, Tiemeier H. Preconception and prenatal cannabis use and the risk of behavioural and emotional problems in the offspring; a multi-informant prospective longitudinal study. Int J Epidemiol. 2018;48:287–96.
El Marroun H, Hudziak JJ, Tiemeier H, Creemers H, Steegers EA, Jaddoe VW, Hofman A, Verhulst FC, van den Brink W, Huizink AC. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend. 2011;118(2–3):470–4.
Metz TD, Allshouse AA, Hogue CJ, Goldenberg RL, Dudley DJ, Varner MW, Conway DL, Saade GR, Silver RM. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstetr Gynecol. 2017;217(4):478e471–8.
Narendran N, Yusuf K. Marijuana use during pregnancy and lactation and long-term outcomes. NeoReviews. 2021;22(8):e521–30.
O’Connor AB, Kelly BK, O’Brien LM. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. Drug Alcohol Depend. 2017;180:200–3.
Skelton KR, Hecht AA, Benjamin-Neelon SE. Association of recreational cannabis legalization with maternal cannabis use in the preconception, prenatal, and postpartum periods. JAMA Netw Open. 2021;4(2):e210138.
Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA. 2017;317(2):207–9.
Volkow ND, Han B, Compton WM, McCance-Katz EF. Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA. 2019;322(2):167–9.
Young-Wolff KC, Sarovar V, Tucker LY, Conway A, Alexeeff S, Weisner C, Armstrong MA, Goler N. Self-reported daily, weekly, and monthly cannabis use among women before and during pregnancy. JAMA Netw Open. 2019;2(7):e196471.
Meinhofer A, Witman A, Murphy SM, Bao Y. Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women. Addiction (Abingdon, England). 2019;114(9):1593–601.
Bakhireva LN, Lowe JR, Gutierrez HL, Stephen JM. Ethanol, Neurodevelopment, Infant and Child Health (ENRICH) prospective cohort: study design considerations. Adv Pediatr Res. 2015;2015:2.
Jacobson SW, Chiodo LM, Sokol RJ, Jacobson JL. Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome. Pediatrics. 2002;109(5):815–25.
National Survey on Drug Use and Health: ICPSR 34481-v3. Ann Arbor (MI): US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality; 2011.
Grant TM, Graham JC, Carlini BH, Ernst CC, Brown NN. Use of marijuana and other substances among pregnant and parenting women with substance use disorders: changes in washington state after marijuana legalization. J Stud Alcohol Drugs. 2018;79(1):88–95.
Ko JY, Farr SL, Tong VT, Creanga AA, Callaghan WM. Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age. Am J Obstet Gynecol. 2015;213(2):201.e201-201.e210.
Chang JC, Tarr JA, Holland CL, De Genna NM, Richardson GA, Rodriguez KL, Sheeder J, Kraemer KL, Day NL, Rubio D, et al. Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use. Drug Alcohol Depend. 2019;196:14–20.
Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai’i. Hawaii J Med Public Health. 2014;73(9):283–7.
Young-Wolff KC, Conway A, Goler N. Why pregnant women may justifiably choose to use cannabis-reply. JAMA Intern Med. 2019;179(1):120–1.
Committee on Obstetric P. Committee Opinion No. 722: Marijuana use during pregnancy and lactation. Obstetr Gynecol. 2017;130(4):e205–e209.
Jarlenski M, Tarr JA, Holland CL, Farrell D, Chang JC. Pregnant women’s access to information about perinatal marijuana use: a qualitative study. Womens Health Issues. 2016;26(4):452–9.
Clem SN, Bigand TL, Wilson M. Cannabis use motivations among adults prescribed opioids for pain versus opioid addiction. Pain Manag Nurs. 2019;21:43.
Dai H, Richter KP. A National Survey of Marijuana use among us adults with medical conditions, 2016–2017. JAMA Netw Open. 2019;2(9):e1911936.
Keyhani S, Steigerwald S, Ishida J, Vali M, Cerda M, Hasin D, Dollinger C, Yoo SR, Cohen BE. Risks and benefits of marijuana use: a national survey of U.S. adults. Ann Intern Med. 2018;169(5):282–90.
Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J Anal Toxicol. 2008;32(8):562–9.
Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997;167:17–36.
Buchan BJ, Dennis ML, Tims FM, Diamond GS. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction (Abingdon, England). 2002;97(Suppl 1):98–108.
Sherman MF, Bigelow GE. Validity of patients’ self-reported drug use as a function of treatment status. Drug Alcohol Depend. 1992;30(1):1–11.
Garg M, Garrison L, Leeman L, Hamidovic A, Borrego M, Rayburn WF, Bakhireva L. Validity of self-reported drug use information among pregnant women. Matern Child Health J. 2016;20(1):41–7.
Oh S, Salas-Wright CP, Vaughn MG, DiNitto DM. Marijuana use during pregnancy: a comparison of trends and correlates among married and unmarried pregnant women. Drug Alcohol Depend. 2017;181:229–33.
Elliott TE, Frail CK, Pawloski PA, Thomas AJ, Werner AM, Rossom RC. Opioid use during pregnancy, observations of opioid use, and secular trend from 2006 to 2014 at HealthPartners Medical Group. Clin J Pain. 2018;34(8):707–12.
Subbaraman MS, Kerr WC. Alcohol use and risk of related problems among cannabis users is lower among those with medical cannabis recommendations, though not due to health. J Stud Alcohol Drugs. 2018;79(6):935–42.
Duncan GJ, Wilkerson B, England P. Cleaning up their act: the effects of marriage and cohabitation on licit and illicit drug use. Demography. 2006;43(4):691–710.
Merline AC, Schulenberg JE, O’Malley PM, Bachman JG, Johnston LD. Substance use in marital dyads: premarital assortment and change over time. J Stud Alcohol Drugs. 2008;69(3):352–61.
Fals-Stewart W, Birchler GR, O’Farrell TJ. Drug-abusing patients and their intimate partners: dyadic adjustment, relationship stability, and substance use. J Abnorm Psychol. 1999;108(1):11–23.
Rhodes T, Rance J, Fraser S, Treloar C. The intimate relationship as a site of social protection: partnerships between people who inject drugs. Soc Sci Med. 2017;180:125–34.
Washio Y, Martin CE, Goldstein ND, Terplan M. Characteristics of pregnant women who reported alcohol use at admission to substance use treatment. J Subst Abuse Treat. 2017;82:82–6.
Garrison L, Leeman L, Savich RD, Gutierrez H, Rayburn WF, Bakhireva LN. Fetal growth outcomes in a cohort of polydrug- and opioid-dependent patients. J Reprod Med. 2016;61(7–8):311–9.
Jansson LM, Velez ML, McConnell K, Spencer N, Tuten M, Jones H, Rios R, King VL, Gandotra N, Millio L, et al. Maternal buprenorphine treatment and infant outcome. Drug Alcohol Depend. 2017;180:56–61.
New Mexico Department of Health: Medical Cannabis Program. https://nmhealth.org/about/mcp/svcs/info/. Accessed 27 Nov 2019.
Fish EW, Murdaugh LB, Zhang C, Boschen KE, Boa-Amponsem O, Mendoza-Romero HN, Tarpley M, Chdid L, Mukhopadhyay S, Cole GJ, et al. Cannabinoids exacerbate alcohol teratogenesis by a CB1-Hedgehog Interaction. Sci Rep. 2019;9(1):16057.
American College of Obstetricians and Gynecologists: Marijuana use during pregnancy and lactation. ACOG Committee Opinion. Interim Update October 2017; reaffirmed 2019. . https://www.acogorg/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Marijuana-Use-During-Pregnancy-and-Lactation?IsMobileSet=false Accessed 28 Nov 2019.
Metz TD, Borgelt LM. Marijuana use in pregnancy and while breastfeeding. Obstet Gynecol. 2018;132(5):1198–210.
Cohen K, Weizman A, Weinstein A. Modulatory effects of cannabinoids on brain neurotransmission. Eur J Neurosci. 2019;50(3):2322–45.
Mohiuddin M, Blyth FM, Degenhardt L, Di Forti M, Eccleston C, Haroutounian S, Moore A, Rice ASC, Wallace M, Park R, et al. General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. Pain. 2021;162(Suppl 1):S80–96.
Badowski S, Smith G. Cannabis use during pregnancy and postpartum. Can Fam Physician. 2020;66(2):98–103.
Ryan SA, Ammerman SD, O'Connor ME, Committee On Substance USE, Prevention, Section On B. Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics. 2018;142(3).
Marufu TC, Ahankari A, Coleman T, Lewis S. Maternal smoking and the risk of still birth: systematic review and meta-analysis. BMC Public Health. 2015;15:239.
Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake during pregnancy and the risk of stillbirth and death in the first year of life. Am J Epidemiol. 2002;155(4):305–12.